ANUHPHRPharmaceuticals
Anuh Pharma Ltd — PE Ratio & Valuation Analysis
₹67.00
-2.77%
Current P/E20.71xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E17.9x15.4% above avg
✅
34.8% Discount to Industry
ANUHPHR P/E 20.71x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹4.72 | ₹81 | 17x |
| 2024 | ₹5.99 | ₹113 | 18.9x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Anuh Pharma Ltd Valuation
Anuh Pharma Ltd (ANUHPHR) currently trades at 20.71x earnings. The Pharmaceuticals sector average PE is 31.77x. ANUHPHR is trading at a discount to peers — may indicate relative value. Historically, ANUHPHR has traded at an average PE of 17.9x — it is currently above that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
13.41%
Dividend Yield
1.88%
More on Anuh Pharma Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.